Global Bioinformatics Market Analysis By Industry Growth, Size, Share, Demand, Trends and Research Report

SDKI Inc. published a new report on the Global Bioinformatics Market-Forecast 2022-2030. This study includes the statistical and analytical approaches needed to grow the bioinformatics market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111649

The bioinformatics market is estimated to grow from US $ 11.60 billion in 2022 to US $ 26.67 billion by 2030, with a CAGR of 13.4% during the 2022-2030 forecast period.

Bioinformatics is a fusion of biology and information technology, and storage and distribution of biology data and information. , Combines evaluation methods to support different areas of scientific research, including bioinformatics. It is also widely used in the field of medical research and drug development for the management of biological data. Bioinformatics often leverages computer software tools for database creation, data mining, data warehousing, data management, and communication networking. Thus, bioinformatics was widely accepted as the large amount of data generated by this technology and was needed for potential research and medical purposes.

The advent of user-friendly and out-of-the-box bioinformatics software such as RasMol, AUTODOCK, and BALL, and the exponential use of these tools for accurate and efficient evaluation of biomarker discovery programs, will lead to bioinformatics during the forecast period. We are driving the growth of the market. In addition, the rapid increase in drug discovery and development funding and the increased utility of protein sequencing and nucleic acids by reducing sequencing costs are also contributing to the growth of the bioinformatics market. The Government of India initiative "PharmaVision 2020" aims to make India a major hub for drug discovery. To achieve this initiative, the Government of India will invest US $ 942.8 million worth of funds in 2020 to build three mega-drug parks that promote sustainable cost-effectiveness. Similarly, in May 2020, the US Government signed a four-year contract with a new pharmaceutical company, Phlow Corp., for US $ 354 million to expand domestic drug or drug production. This is expected to enhance the growth of the bioinformatics market around the world.

However, the lack of well-characterized standards, and the usual data formats for incorporating data, could curb the growth of the bioinformatics market during the 2022-2030 forecast period.

Sample URL for the report
https://www.sdki.jp/sample-request-111649

Bioinformatics market segment

The bioinformatics market is by technology and service (knowledge management tools, bioinformatics platform, bioinformatics service), by application (metabolomics, molecular phylogeny, genomics, proteomics, etc.) and by end user (medical bioinformatics, animal bioinformatics). , Agricultural bioinformatics, academic, etc.), and by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional overview

bioinformatics market The bioinformatics market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, UK, and other Europe), Asia Pacific (China, Japan, India, Australia, Singapore, and others). Asia Pacific) and other regions.

North America is the world's leading region in terms of market share. This is due to the growing initiative in drug discovery and development and genomic research, as well as the large number of market vendors in the region. Meanwhile, the Asia Pacific bioinformatics market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030). Factors such as the high adoption of IoT technology in the bioinformatics industry and increased government funding for drug development in developing countries such as China and India provide favorable growth opportunities for the bioinformatics market in the Asia-Pacific region. Produce.

key player in the bioinformatics market

Key players in the bioinformatics market include Agilent Technologies, Inc., Biomax Informatics AG, Danexus, Inc., Genedata AG, Intrexon Bioinformatics Germany GmbH, Illumina, Inc., PerkinElmer, Inc., QIAGEN NV, Seven Bridges Genomics. , Inc., Thermo Fisher Scientific, Inc. and more. The survey includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these key companies in the bioinformatics market.

Details of the survey report
https://www.sdki.jp/press-details/global-bioinformatics-market/178

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.